SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-091743
Filing Date
2022-03-31
Accepted
2022-03-31 16:06:42
Documents
14
Period of Report
2022-03-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d293780d8k.htm   iXBRL 8-K 43529
2 EX-10.1 d293780dex101.htm EX-10.1 125724
  Complete submission text file 0001193125-22-091743.txt   357371

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA veru-20220329.xsd EX-101.SCH 3229
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE veru-20220329_def.xml EX-101.DEF 13395
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE veru-20220329_lab.xml EX-101.LAB 21922
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE veru-20220329_pre.xml EX-101.PRE 14193
8 EXTRACTED XBRL INSTANCE DOCUMENT d293780d8k_htm.xml XML 4859
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-13602 | Film No.: 22792453
SIC: 2834 Pharmaceutical Preparations